Viewing Study NCT02573259


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2025-12-24 @ 2:40 PM
Study NCT ID: NCT02573259
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2015-10-06
Is Possible Gene Therapy: False
Has Adverse Events: True

Brief Title: A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-02-10
Start Date Type: ACTUAL
Primary Completion Date: 2020-11-19
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-19
Completion Date Type: ACTUAL
First Submit Date: 2015-10-06
First Submit QC Date: None
Study First Post Date: 2015-10-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-09-13
Results First Submit QC Date: None
Results First Post Date: 2021-12-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-29
Last Update Post Date: 2021-12-13
Last Update Post Date Type: ACTUAL